Comparison of Adjuvant Treatment With 177Lu-DOTATATE to Best Supportive Care in Patients After Resection of Neuroendocrine Liver Metastases

Clinical trial NCT05987176 · TERMINATED

Trial details

NCT number: NCT05987176
Sponsor: Imperial College London
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Neuroendocrine Tumor G1 (NET G1)/Carcinoid Neuroendocrine Tumor Grade 2 Neuroendocrine Tumors Liver Metastases Gastroenteropancreatic Neuroendocrine Tumor Gastroenteropancreatic Neuroendocrine Neoplasm

Start date: 2024-08-02
Primary completion: 2025-10-21
Enrollment: 1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.